The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

People are beginning to realize that dogs share a lot more with humans than just their homes and habits. Some spontaneously occurring cancers in dogs are genetically very similar to those in people ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

Though biomarker testing isn’t routinely performed for SCLC, certain cases—such as never-smokers or large-cell neuroendocrine lung cancer patients—may benefit from genomic analysis.

Appendix cancer is rare but it can still affect anyone The key is to stay vigilant watch out for early signs and take ...

Ratio Therapeutics and Ionetix have inked separate deals to boost production of the much-needed radioisotope actinium-225, ...

Think Steve Jobs created the iPhone? The real story might surprise you — here’s who actually designed Apple’s iconic device.

Lantheus Holdings offers a compelling bull case, with PYLARIFY and DEFINITY driving valuation and strong growth prospects.

Analysts at Nova One Advisor are currently projecting the global oncology drug market to hit US$366.24 billion by 2034, expanding at a 7.4% ...

U.S. stock markets have suffered a setback in 2025 after the artificial intelligence (AI)-driven astonishing bull run of 2023 ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss ...